ArcticDx develops test to determine inherited risk for AMD

[News]

Established in 2007 and based in Toronto, ArcticDx has developed a test, Macula Risk-, the first of its kind and specifically designed to determine one's inherited risk for age-related macular degeneration (AMD), the most common form of acquired blindness in the developed world, affecting over 10% of individuals. ArcticDx will use the PBDF investment to undertake studies in support of a planned filing for Food and Drug Administration (FDA) approval for Macula Risk.

More... (http://www.news-medical.net/news/20101102/ArcticDx-develops-test-to-determine-inherited-risk-for-AMD.aspx)